NextGen Biomed (XTAE:NXGN) Institutional Ownership : 0.02% (As of Jun. 07, 2024)

View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NextGen Biomed's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NextGen Biomed's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NextGen Biomed's Float Percentage Of Total Shares Outstanding is 0.00%.

NextGen Biomed Institutional Ownership Historical Data

The historical data trend for NextGen Biomed's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextGen Biomed Institutional Ownership Chart

NextGen Biomed Historical Data

The historical data trend for NextGen Biomed can be seen below:

	2021-01-31	2021-02-28	2022-01-31	2022-02-28	2022-03-31	2022-04-30	2022-05-31	2022-07-31	2022-08-31	2023-05-31
Institutional Ownership	0.01	0.01	0.02	0.02	0.06	0.06	0.02	0.02	0.02	0.02

NextGen Biomed Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

NextGen Biomed (XTAE:NXGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101

Website

http://www.nextgen-biomed.com

NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.